Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GSK-Merck back new developing world cancer charity

September 14, 2011
Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer

GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …

News
GlaxoSmithKline

GSK-Amicus start late-stage trials of Fabry disease treatment

September 14, 2011
Research and Development Amicus Therapeutics, Fabry disease, GSK

GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …

News

GSK scales back breast cancer trial

September 12, 2011
Research and Development, Sales and Marketing GSK, Tyverb

GSK has halted one of the four phase III studies that make up the ALTTO programme for its cancer drug …

News

Dendreon drops GSK as Provenge manufacturing partner

September 8, 2011
Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news

Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …

News
GlaxoSmithKline

GSK invests in UK biotech start-up

August 22, 2011
Research and Development Autifony, GSK, biotech, hearing loss, research and development news

GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …

News
GlaxoSmithKline

GSK Parkinson’s drug shows motor skills benefits

August 16, 2011
Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

News

GSK moves into diagnostics with Enigma

August 12, 2011
Sales and Marketing Diagnostics, GSK, infectious diseases

GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …

News

Witty backs Britain as manufacturing, R&D location

July 29, 2011
Manufacturing and Production, Research and Development GSK

GlaxoSmithKline chief executive Andrew Witty has promised to expand operations in the UK in both manufacturing and R&D, saying that …

News
GlaxoSmithKline

GSK sales down on Avandia and pandemic products

July 27, 2011
Research and Development, Sales and Marketing GSK

GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …

News
Augmentin tablets

Augmentin recall expanded on contamination fears

July 26, 2011
Manufacturing and Production, Sales and Marketing Augmentin, GSK, recalls

GlaxoSmithKline has been drawn further into concerns about contamination of pharmaceuticals, foods and beverages with plasticiser compounds, after authorities in …

News
GlaxoSmithKline

GSK downsizes Irish OTC plant

July 18, 2011
Manufacturing and Production GSK, Ireland, pharma manufacturing news

GlaxoSmithKline is cutting around 130 jobs at a facility in Waterford, Ireland, over the next three years as part of …

News
GlaxoSmithKline

GSK changes the way its US sales reps are assessed

July 6, 2011
Sales and Marketing GSK, pharma sales force

GlaxoSmithKline has revealed a new way of assessing its US sales representatives’ performance in a bid to make the manufacturer’s …

News
GlaxoSmithKline

GSK welcomes outside researchers to its ‘open lab’

June 29, 2011
Research and Development GSK, TB, academic alliance, malaria, open lab

The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …

News

GlaxoSmithKline fined $41m for manufacturing failings

June 28, 2011
Manufacturing and Production GSK, pharma manufacturing news

GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …

News

NICE guideline helping to cut referrals

June 20, 2011
GSK, NICE, bph

A NICE guideline on treating lower urinary tract symptoms (LUTS) in men is helping to cut referrals to urologists, thereby …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025